A follow-up study: Acute behavioural effects of Δ9-THC in female heterozygous Neuregulin 1 transmembrane domain mutant mice

Psychopharmacology

Volumn 211, Issue 3, 2010, Pages 277-289

  Long, Leonora E ^a,b,d,e   Chesworth, Rose ^a,b,d   Arnold, Jonathon C ^a,c,f   Karl, Tim ^a,b,d,e  

^a SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c University of Sydney   (Australia)

^d NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anxiety; Cannabinoid; Exploration; Memory; Motor activity; Neuregulin 1; Prepulse inhibition; Schizophrenia; Sensorimotor gating; THC

Indexed keywords

CANNABIS; DRONABINOL; NEU DIFFERENTIATION FACTOR;

ANXIETY; ARTICLE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; GENE MUTATION; GENOTYPE; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; RECOGNITION; SCHIZOPHRENIA; SENSORY GATING; SOCIAL INTERACTION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; FEMALE; GENETICS; HETEROZYGOTE; MEMORY; MOTOR ACTIVITY; MUTANT MOUSE STRAIN; SOCIAL BEHAVIOR; STARTLE REFLEX;

ANIMALS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; GENOTYPE; HETEROZYGOTE; MAZE LEARNING; MEMORY; MICE; MICE, MUTANT STRAINS; MOTOR ACTIVITY; NEUREGULIN-1; SCHIZOPHRENIA; SOCIAL BEHAVIOR; STARTLE REACTION; TETRAHYDROCANNABINOL; DRONABINOL; REFLEX, STARTLE;

EID: 77955471951     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1896-6     Document Type: Article

References (52)

1. AA Boucher JC Arnold L Duffy PR Schofield J Micheau T Karl 2007 Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta(9)-tetrahydrocannabinol Psychopharmacology 192 325 336 10.1007/s00213-007-0721-3 1:CAS:528:DC%2BD2sXkvFKisLk%3D 17333138 (Pubitemid 46705399)
2. AA Boucher GE Hunt T Karl J Micheau IS McGregor JC Arnold 2007 Heterozygous neuregulin 1 mice display greater baseline and Delta(9)- tetrahydrocannabinol-induced c-Fos expression Neuroscience 149 861 870 10.1016/j.neuroscience.2007.08.020 1:CAS:528:DC%2BD2sXhtlGjs7bF 17905522 (Pubitemid 350122892)
3. DL Braff MA Geyer NR Swerdlow 2001 Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies Psychopharmacology 156 234 258 10.1007/s002130100810 1:CAS:528: DC%2BD3MXmtlCqtbY%3D 11549226 (Pubitemid 32705488)
4. G Brebion RA Bressan AS David LS Pilowsky 2009 Role of processing speed and premorbid IQ on visual recognition in patients with schizophrenia J Clin Exp Neuropsychol 31 302 311 10.1080/13803390802108362 18608649
5. A Caspi TE Moffitt M Cannon J McClay R Murray H Harrington A Taylor L Arseneault B Williams A Braithwaite R Poulton IW Craig 2005 Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene × environment interaction Biol Psychiatry 57 1117 1127 10.1016/j.biopsych.2005.01.026 1:CAS:528:DC%2BD2MXjslKht70%3D 15866551 (Pubitemid 40615773)
6. YM Cha KH Jones CM Kuhn WA Wilson HS Swartzwelder 2007 Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats Behav Pharmacol 18 563 569 10.1097/FBP.0b013e3282ee7b7e 1:CAS:528:DC%2BD2sXpvVemsLg%3D 17762524 (Pubitemid 47356382)
7. Y Chen D Norton R McBain D Ongur S Heckers 2009 Visual and cognitive processing of face information in schizophrenia: detection, discrimination and working memory Schizophr Res 107 92 98 10.1016/j.schres.2008.09.010 18947982
8. VZ Chong M Thompson S Beltaifa MJ Webster AJ Law CS Weickert 2008 Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients Schizophr Res 100 270 280 10.1016/j.schres.2007.12.474 18243664
9. MD De Bellis MS Keshavan SR Beers J Hall K Frustaci A Masalehdan J Noll AM Boring 2001 Sex differences in brain maturation during childhood and adolescence Cereb Cortex 11 552 557 10.1093/cercor/11.6.552 11375916
10. VH Denenberg 1969 Open-field behavior in the rat: what does it mean? Ann N Y Acad Sci 159 852 859 10.1111/j.1749-6632.1969.tb12983.x 1:STN:280: DyaE3c%2FjsVGgsQ%3D%3D 5260302
11. E Dere JP Huston MA De Souza Silva 2007 The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents Neurosci Biobehav Rev 31 673 704 10.1016/j.neubiorev.2007.01.005 1:CAS:528:DC%2BD2sXkvFOmtLY%3D 17368764 (Pubitemid 46670336)
12. BA Ellenbroek AR Cools 2000 Animal models for the negative symptoms of schizophrenia Behav Pharmacol 11 223 233 1:STN:280:DC%2BD3M%2FltVKrsA%3D%3D 11103877
13. B Elvevag TE Goldberg 2000 Cognitive impairment in schizophrenia is the core of the disorder Crit Rev Neurobiol 14 1 21 1:STN:280:DC%2BD3MzjvFSgsA%3D%3D 11253953
14. A Ennaceur J Delacour 1988 A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data Behav Brain Res 31 47 59 10.1016/0166-4328(88)90157-X 1:STN:280:DyaL1M7kvF2gsw%3D%3D 3228475
15. SE File P Seth 2003 A review of 25 years of the social interaction test Eur J Pharmacol 463 35 53 10.1016/S0014-2999(03)01273-1 1:CAS:528: DC%2BD3sXhsVanu7o%3D 12600701 (Pubitemid 36205071)
16. JA Gogos M Morgan V Luine M Santha S Ogawa D Pfaff M Karayiorgou 1998 Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior Proc Natl Acad Sci USA 95 9991 9996 10.1073/pnas.95.17.9991 1:CAS:528:DyaK1cXlsFWjsbc%3D 9707588 (Pubitemid 28415282)
17. L Gray M van den Buuse E Scarr B Dean AJ Hannan 2009 Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation Int J Neuropsychopharmacol 12 45 60 10.1017/S1461145708009085 1:CAS:528:DC%2BD1cXhsFWktbfM 18593507
18. PJ Harrison AJ Law 2006 Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology Biol Psychiatry 60 132 140 10.1016/j.biopsych.2005. 11.002 1:CAS:528:DC%2BD28Xmsl2jur8%3D 16442083
19. PJ Harrison EM Tunbridge 2007 Catechol-O-methyltransferase (COMT): A gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders Neuropsychopharmacology 33 3037 3045 10.1038/sj.npp.1301543 17805313
20. S Hogg 1996 A review of the validity and variability of the elevated plus-maze as an animal model of anxiety Pharmacol Biochem Behav 54 21 30 10.1016/0091-3057(95)02126-4 1:CAS:528:DyaK28XisVOisro%3D 8728535 (Pubitemid 26146661)
21. JR Homberg OJ Schiepers AN Schoffelmeer E Cuppen LJ Vanderschuren 2007 Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats Psychopharmacology 195 175 182 10.1007/s00213-007-0895-8 1:CAS:528:DC%2BD2sXht1Cltb3F 17661017 (Pubitemid 350045847)
22. DC Javitt A-M Shelley W Ritter 2000 Associated deficits in mismatch negativity generation and tone matching in schizophrenia Clin Neurophysiol 111 1733 1737 10.1016/S1388-2457(00)00377-1 1:STN:280:DC%2BD3M%2Fksl2lug%3D%3D 11018486
23. T Karl L Duffy A Scimone RP Harvey PR Schofield 2007 Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia Genes Brain Behav 6 677 687 10.1111/j.1601-183X.2006.00298.x 1:CAS:528:DC%2BD2sXht1Khu7fL 17309661 (Pubitemid 47476190)
24. A Kask HP Nguyen R Pabst S von Horsten 2001 Factors influencing behavior of group-housed male rats in the social interaction test: focus on cohort removal Physiol Behav 74 277 282 10.1016/S0031-9384(01)00587-X 1:CAS:528:DC%2BD3MXosFOjsLg%3D 11714489 (Pubitemid 33070399)
25. T Kircher R Thienel M Wagner M Reske U Habel T Kellermann I Frommann S Schwab W Wolwer M von Wilmsdorf DF Braus A Schmitt A Rapp T Stocker NJ Shah FA Henn H Sauer W Gaebel W Maier F Schneider 2009 Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas Eur Arch Psychiatry Clin Neurosci 259 72 79 10.1007/s00406-008-0837-4 18806920
26. V Kumari I Aasen T Sharma 2004 Sex differences in prepulse inhibition deficits in chronic schizophrenia Schizophr Res 69 219 235 10.1016/j.schres. 2003.09.010 15469195 (Pubitemid 38721421)
27. AJ Law BK Lipska CS Weickert TM Hyde RE Straub R Hashimoto PJ Harrison JE Kleinman DR Weinberger 2006 Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease Proc Natl Acad Sci U S A 103 6747 6752 10.1073/pnas.0602002103 1:CAS:528:DC%2BD28XksVKrtbc%3D 16618933
28. A Leung P Chue 2000 Sex differences in schizophrenia, a review of the literature Acta Psychiatr Scand Suppl 401 3 38 10.1111/j.0065-1591.2000.0ap25.x 1:STN:280:DC%2BD3M%2FivVajsg%3D%3D 10887978
29. Long LE, Chesworth R, Huang X-F, McGregor IS, Arnold JC, Karl T (2009) A behavioural comparison of acute and chronic delta-9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. Int J Neuropsychopharmacol 1-16
30. K Ludewig MA Geyer FX Vollenweider 2003 Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia Biol Psychiatry 54 121 128 10.1016/S0006-3223(02)01925-X 12873801 (Pubitemid 36859771)
31. I Mata R Perez-Iglesias R Roiz-Santianez D Tordesillas-Gutierrez A Gonzalez-Mandly J Luis Vazquez-Barquero B Crespo-Facorro 2009 A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia Biol Psychiatry 65 535 540 10.1016/j.biopsych.2008. 10.020 1:CAS:528:DC%2BD1MXit1Wku7g%3D 19058791
32. IS McGregor JC Arnold 2007 Cannabis reward: biased towards the fairer sex? Br J Pharmacol 152 562 564 10.1038/sj.bjp.0707469 1:CAS:528: DC%2BD2sXht1ejt7%2FP 17891161 (Pubitemid 350034989)
33. L Mei WC Xiong 2008 Neuregulin 1 in neural development, synaptic plasticity and schizophrenia Nat Rev Neurosci 9 437 452 10.1038/nrn2392 1:CAS:528:DC%2BD1cXmtVahur0%3D 18478032 (Pubitemid 351704944)
34. R Misslin P Ropartz 1981 Responses in mice to a novel object Behaviour 78 169 177 10.1163/156853981X00301
35. THM Moore S Zammit A Lingford-Hughes TRE Barnes PB Jones M Burke G Lewis 2007 Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review Lancet 370 319 328 10.1016/S0140-6736(07)61162-3 17662880 (Pubitemid 47094993)
36. SS Moy JJ Nadler A Perez RP Barbaro JM Johns TR Magnuson J Piven JN Crawley 2004 Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice Genes Brain Behav 3 287 302 10.1111/j.1601-1848.2004.00076.x 1:STN:280:DC%2BD2cvjvFektQ%3D%3D 15344922 (Pubitemid 39277416)
37. MR Munafo DL Thiselton TG Clark J Flint 2006 Association of the NRG1 gene and schizophrenia: a meta-analysis Mol Psychiatry 11 539 546 10.1038/sj.mp.4001817 1:CAS:528:DC%2BD28XkvVyrtLc%3D 16520822
38. CM O'Tuathaigh GJ O'Sullivan A Kinsella RP Harvey O Tighe DT Croke JL Waddington 2006 Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice NeuroReport 17 79 83 10.1097/01.wnr.0000192738.31029.0a 16361955 (Pubitemid 43005745)
39. CMP O'Tuathaigh D Babovic GJ O'Sullivan JJ Clifford O Tighe DT Croke R Harvey JL Waddington 2007 Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1 Neuroscience 147 18 27 10.1016/j.neuroscience.2007.03.051 17512671 (Pubitemid 46873845)
40. CM O'Tuathaigh AM O'Connor GJ O'Sullivan D Lai R Harvey DT Croke JL Waddington 2008 Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1 Prog Neuropsychopharmacol Biol Psychiatry 32 462 466 10.1016/j.pnpbp.2007.09.018 17980471 (Pubitemid 351178964)
41. S Pellow P Chopin SE File M Briley 1985 Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Meth 14 149 167 10.1016/0165-0270(85)90031-7 1:STN:280:DyaL28%2Fht12htw%3D%3D (Pubitemid 16239568)
42. SB Powell MA Geyer D Gallagher MP Paulus 2004 The balance between approach and avoidance behaviors in a novel object exploration paradigm in mice Behav Brain Res 152 341 349 10.1016/j.bbr.2003.10.020 15196802 (Pubitemid 38757905)
43. SB Powell X Zhou MA Geyer 2009 Prepulse inhibition and genetic mouse models of schizophrenia Behav Brain Res 204 282 294 10.1016/j.bbr.2009.04.021 1:CAS:528:DC%2BD1MXhtVKns7jI 19397931
44. ML Rao H Kölsch 2003 Effects of estrogen on brain development and neuroprotection-implications for negative symptoms in schizophrenia Psychoneuroendocrinology 28 83 96 10.1016/S0306-4530(02)00126-9 1:CAS:528:DC%2BD3sXitVynurg%3D 12650683 (Pubitemid 36332231)
45. JP Rung A Carlsson K Ryden Markinhuhta ML Carlsson 2005 (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 29 827 832 10.1016/j.pnpbp.2005.03.004 1:CAS:528:DC%2BD2MXlslymurw%3D 15916843 (Pubitemid 40897800)
46. A Sazci E Ergul I Kucukali G Kilic G Kaya I Kara 2004 Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women Mol Brain Res 132 51 56 10.1016/j.molbrainres.2004.09.005 1:CAS:528:DC%2BD2cXhtVSktr3J 15548428 (Pubitemid 39531351)
47. S Shifman M Johannesson M Bronstein SX Chen DA Collier NJ Craddock KS Kendler T Li M O'Donovan FA O'Neill MJ Owen D Walsh DR Weinberger C Sun J Flint A Darvasi 2008 Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women PLoS Genet 4 e28 10.1371/journal.pgen.0040028 18282107 (Pubitemid 351328535)
48. H Stefansson E Sigurdsson V Steinthorsdottir S Bjornsdottir T Sigmundsson S Ghosh J Brynjolfsson S Gunnarsdottir O Ivarsson TT Chou O Hjaltason B Birgisdottir H Jonsson VG Gudnadottir E Gudmundsdottir A Bjornsson B Ingvarsson A Ingason S Sigfusson H Hardardottir RP Harvey D Lai M Zhou D Brunner V Mutel A Gonzalo G Lemke J Sainz G Johannesson T Andresson D Gudbjartsson A Manolescu ML Frigge ME Gurney A Kong JR Gulcher H Petursson K Stefansson 2002 Neuregulin 1 and susceptibility to schizophrenia Am J Hum Genet 71 877 892 10.1086/342734 12145742
49. AH Tseng RM Craft 2001 Sex differences in antinociceptive and motoric effects of cannabinoids Eur J Pharmacol 430 41 47 10.1016/S0014-2999(01)01267-5 1:CAS:528:DC%2BD3MXotFWiur0%3D 11698061 (Pubitemid 33042709)
50. AH Tseng JW Harding RM Craft 2004 Pharmacokinetic factors in sex differences in [Delta]9-tetrahydrocannabinol-induced behavioral effects in rats Behav Brain Res 154 77 83 10.1016/j.bbr.2004.01.029 1:CAS:528: DC%2BD2cXmsVGitrw%3D 15302113 (Pubitemid 39070455)
51. M van den Buuse L Wischhof R Xi Lee S Martin T Karl 2009 Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation Int J Neuropsychopharmacol 12 1383 1393 10.1017/S1461145709000388 19400983
52. J van Os S Kapur 2009 Schizophrenia Lancet 374 635 645 10.1016/S0140-6736(09)60995-8 19700006